Rubinstein P, Dobrila L, Rosenfield R E, Adamson J W, Migliaccio G, Migliaccio A R, Taylor P E, Stevens C E
Laboratory of Immunogenetics, Lindsley F. Kimball Research Institute of the New York Blood Center, NY 10021, USA.
Proc Natl Acad Sci U S A. 1995 Oct 24;92(22):10119-22. doi: 10.1073/pnas.92.22.10119.
Clinical evidence of hematopoietic restoration with placental/umbilical cord blood (PCB) grafts indicates that PCB can be a useful source of hematopoietic stem cells for routine bone marrow reconstitution. In the unrelated setting, human leukocyte antigen (HLA)-matched donors must be obtained for candidate patients and, hence, large panels of frozen HLA-typed PCB units must be established. The large volume of unprocessed units, consisting mostly of red blood cells, plasma, and cryopreservation medium, poses a serious difficulty in this effort because storage space in liquid nitrogen is limited and costly. We report here that almost all the hematopoietic colony-forming cells present in PCB units can be recovered in a uniform volume of 20 ml by using rouleaux formation induced by hydroxyethyl starch and centrifugation to reduce the bulk of erythrocytes and plasma and, thus, concentrate leukocytes. This method multiples the number of units that can be stored in the same freezer space as much as 10-fold depending on the format of the storage system. We have also investigated the proportion of functional stem/progenitor cells initially present that are actually available to the recipient when thawed cryopreserved PCB units are infused. Progenitor cell viability is measurably decreased when thawed cells, still suspended in hypertonic cryopreservative solutions, are rapidly mixed with large volumes of isotonic solutions or plasma. The osmotic damage inflicted by the severe solute concentration gradient, however, can be averted by a simple 2-fold dilution after thawing, providing almost total recovery of viable hematopoietic progenitor cells.
胎盘/脐带血(PCB)移植实现造血恢复的临床证据表明,PCB可作为常规骨髓重建中造血干细胞的有用来源。在非亲属供者情况下,必须为候选患者找到人类白细胞抗原(HLA)匹配的供者,因此,必须建立大量冷冻的HLA分型PCB单位。大量未处理的单位,主要由红细胞、血浆和冷冻保存介质组成,给这项工作带来了严重困难,因为液氮中的存储空间有限且成本高昂。我们在此报告,通过使用羟乙基淀粉诱导的红细胞缗钱状形成和离心来减少红细胞和血浆的体积,从而浓缩白细胞,几乎所有PCB单位中存在的造血集落形成细胞都可以在20毫升统一体积中回收。根据存储系统的形式,这种方法可将能够存储在相同冷冻空间中的单位数量增加多达10倍。我们还研究了冷冻保存的PCB单位解冻后输注时,最初存在的功能性干/祖细胞中实际可供受者使用的比例。当仍悬浮在高渗冷冻保存溶液中的解冻细胞与大量等渗溶液或血浆快速混合时,祖细胞活力会明显降低。然而,通过解冻后简单的2倍稀释可以避免严重溶质浓度梯度造成的渗透损伤,从而使存活的造血祖细胞几乎完全恢复。